Mantle cell lymphoma (MCL) is a malignant lymphoproliferative B-cell disorder that does not occur spontaneously in mice but experimental mice model have been developed. Recently two different mice models prone to develop MCL-like lymphomas were generated: c-myc-3'RR/Cdk4 R24C mice and c-myc-3'RR/p53 +/-mice. Comparison of their gene expression profiles does not highlight specific differences other than those in relation with their specific mutational status (i.e., Cdk4 R24C mutation or p53 mutation). We propose that similarly to typical human MCL and its blastoid or cyclin-D1 variants that correspond to the same genetic entity, MCL-like lymphomas of c-myc-3'RR/ p53 +/-mice and c-myc-3'RR/Cdk4 R24C mice represent a spectrum of the same entity.
INTRODUCTION
Mantle cell lymphoma (MCL) is a malignant lymphoproliferative B-cell disorder derived from naïve pregerminal center CD5 + cells [1] . MCL is strongly associated with the t (11, 14) chromosomal translocation leading to overexpression of cyclin D1. Cyclin D1-negative MCL do no express high amounts of cyclin D1 but elevated cyclin D2 or cyclin D3 ones and share the same secondary genetic aberrations that typical MCL supporting the concept that they correspond to the same genetic entity [1] . MCL does not occur spontaneously in mice but experimental mice model have been developed. Old Eµ-cyclin D1 transgenic mice developed CD19 
CD23
-MCL under stimulation by pristine, a pro-inflammatory tumor promoter [2] . Interleukin 14 alpha (IL-14α)/c-myc double transgenic mice developed lymphomas reproducing many features of blastoid variant of MCL [3] . Recently we generated two different mice models prone to develop MCL-like lymphomas. The first one uses the Cdk4-Arg24Cys (R24C) mutation that abolishes the ability of all four INK4 members to bind Cdk4. Disruption of Cdk4 regulation by INK4 while c-myc is overexpressed in B-cells (in a c-myc-3'RR transgenic background prone to develop Burkitt lymphoma (BL)-like lymphomas [4] ) leads to the development (in double mutant c-myc-3'RR/Cdk4 R24C mice) of lymphoid malignancies closely resembling human MCL [5] . The second is relevant to the frequent loss of p53 function observed in human lymphomas, underscoring its critical role in suppressing the emergence of incipient tumors. Double mutant c-myc-3'RR/p53 +/-mice developed a wide pattern of lymphomas including MCL-like lymphomas [6] . It remains unclear what are the common molecular and genetic pathways explaining the convergence of these two mice models towards the same lymphoma phenotype. In both situations, MCL-like lymphomas express similar membrane B-cell differentiation markers (B220 
MATERIAL AND METHODS
Our research has been approved by the ethics committee review board of our University (Limoges, France) and hospital (CHU Dupuytren, Limoges, France). Animal works has been conducted according to French laws. c-myc-3'RR transgenic mice are prone to BL-like lymphomas [4] . In c-myc-3'RR mice, c-myc is specifically expressed from the pre-B to the mature B-cell stages; the 3'RR being active in late B cell lymphopoiesis [7] [8] [9] . Generation of c-myc-3'RR/Cdk4 R24C and c-myc-3'RR/ p53 +/-mice in similar genetic background and their MCL-like lymphoma development have been previously reported [5, 6] . mRNA was extracted from MCL-like lymphoma cases by sorting tumoral cells with CD19-coupled beads (Miltenyi Biotech, Bergisch Gladbach, Germany). Microarray experiments were done in "NiceSophia Antipolis Microarray Facility" (France). Statistical analysis was made with the Bioconductor open source software, particularly its Limma package. The microarray data presented in this article have been submitted to the Gene Expression Omnibus database (www.ncbi.nlm.nih. gov/geo/) under the accession numbers GSE36808.
RESULTS AND DISCUSSION
The gene expression profile of MCL-like lymphomas of c-myc-3'RR/Cdk4 R24C mice was compared with the one of c-myc-3'RR/p53 +/-mice using an array of 44,000 genes. A Log score >2, a Log ratio >2 or <-2 and a p<0.05 was used as cut of. Among these 44,000 genes, only 176 significantly differed (Tables 1, 2, 3 and 4) . Noticeably, differential expression of multiple genes involved in growth, metabolism and signalling (97/176, 55.1%, Table  1 ), diabetes and obesity (31/176, 17.6%, Table 2 )and cellular architecture (23/176, 13.0%, Table 3 ) were found. Thirty two unknown genes significantly differed (32/176, 18.1%, Table 4 ). Of note some genes can be found both in Table 1 , 2 and/or 3.
Differences concerning genes involved in diabetes and obesity (such as Abcc8, Trf, apoc1 and IGF-1) appear directly linked to the Cdk4 R24C mutation since loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia [10] . The metabolic and endocrinic changes resulting from diabetes and obesity may dysregulate DNA repair, gene functions and cell mutation rate favouring neoplastic transformation and leading to hematologic malignancy and cancer [11] . For example IGF-1 (insulin growth factor 1) transcripts are markedly elevated in MCL-like lymphomas of c-myc-3'RR/Cdk4 R24C mice; IGF-1 involvement being well documented in cancer [11] . Differences concerning genes implicated in the growth and signalling processes could be explained by the Cdk4 R24C and p53 mutations themselves. For example, up-regulation of the cell cycle regulatory genes Ccnb1 and Cdc20 in MCL-like lymphomas of c-myc-3'RR/p53 +/-mice appear directly linked to the p53 +/-mutation that increases the rate and occurrence of c-myc-induced lymphomas [6, 12] . Indeed, Ccnb1 overexpression in lymphomas is caused by nonfunctional p53 [13] , while Cdc20 is negatively regulated by p53 [14] . In turn the down regulation of the Cdk4 inhibitor Cdkn2a in MCL-like lymphomas of c-myc-3'RR/Cdk4 R24C mice appears related to its inefficiency in Cdk4 R24C mice. As a consequence of a higher proliferation rate, several genes implicated in cell metabolism (such as Adarb1, Lmo1, AK4, Slc2a4) and nuclear membrane or chromosome stability (such as Lmnb1 and Cenpi) are higher in MCL-like lymphomas of c-myc-3'RR/p53 +/-mice than in MCL-like lymphomas of c-myc-3'RR/ Cdk4 R24C mice. Finally and also linked to a higher rate of proliferation, several differences are found concerning genes implicated in cellular architecture especially on the actin and microtubule cytoskeletons (such as advillin Kif18b, Mtus2, Tubb2b, Mtap2, Stmn1), key players that underpin growth processes [15] .
MCL-like lymphomas of c-myc-3'RR/p53 +/-mice are more aggressive than those of c-myc-3'RR/Cdk4 R24C mice despite similar flow cytometry profiles [5, 6] . Comparison of their gene expression profiles explains this difference by a marked overexpression of several cell cycle regulatory genes. Gene expression profiles do not highlight other specific differences other than those in relation with their specific mutational status (i.e., Cdk4 R24C or p53 mutations). We propose that similarly to typical human MCL and its 
